Enhanced penetration of CEQUA

NCELL technology helps deliver more cyclosporine to ocular tissues1,2

Cyclosporine (0.05%) with NCELL vs cyclosporine (0.05%) emulsion

In a single-dose, preclinical study of cyclosporine delivered with NCELL technology vs a commercially available cyclosporine emulsion1,2,a:

Nearly 3X more penetrated the cornea
1.6X more penetrated the conjunctiva